WHO ICTRP trial
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2…
JPRN-jRCT2031210019 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2031210019 |
|---|---|
| Public title | A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes (AWARD-JPN ) |
| Scientific title | A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Two Doses of Dulaglutide in Combination with a Single Oral Antihyperglycemic Medication or as Monotherapy in Japanese Patients with Type 2 Diabetes Mellitus (AWARD-JPN : Assessment of Weekly AdministRation of LY2189265 in… |
| Primary sponsor | Masaki Takeshi |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Conditions | Type 2 diabetes |
| Interventions | Experimental: 1.5 mg Dulaglutide Active Comparator: 0.75 mg Dulaglutide |
| Registration date | Jun 4, 2021 |
| Target size | 585 |
| Secondary IDs | NCT04809220 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: